Citigroup Upgrades Ovintiv to Buy, Raises Price Target to $43
Citigroup analyst Brian Downey upgrades Ovintiv (NYSE:OVV) from Neutral to Buy and raises the price target from $34 to $43.
Morgan Stanley Maintains Overweight on Ovintiv, Raises Price Target to $42
Morgan Stanley analyst Devin McDermott maintains Ovintiv (NYSE:OVV) with a Overweight and raises the price target from $35 to $42.
Analyzing Ovintiv’s Ex-Dividend Date
Ovintiv (NYSE:OVV) declared a dividend payable on June 30, 2021 to its shareholders as of April 28, 2021. It was also announced that shareholders of Ovintiv's stock as of June 15, 2021 are entitled to the dividend. The stock is expected to become ex-dividend 1 business day(s) before the record date.
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET on Friday, 216 companies hit new 52-week highs.
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 86 companies set new 52-week highs.
Barclays Upgrades Ovintiv to Overweight, Raises Price Target to $33
Barclays analyst Jeanine Wai upgrades Ovintiv (NYSE:OVV) from Underweight to Overweight and raises the price target from $21 to $33.
Stocks That Hit 52-Week Highs On Wednesday
On Wednesday morning, 261 companies achieved new highs for the year.
JP Morgan Upgrades Ovintiv to Overweight, Announces $32 Price Target
JP Morgan analyst Arun Jayaram upgrades Ovintiv (NYSE:OVV) from Neutral to Overweight and announces $32 price target.